N,N-Diethyl-2-bromo-5-methylbenzylamine, 97%, 500mg

N-(2-Methoxyethyl)-1-methylpiperidin-4-amine, 95.0%, 25g

5-Bromo-1,2-dihydroacenaphthylene, 95.0%, 5g

1-(6-Bromopyridin-2-yl)ethanol, 95.0%, 10g

Flat flange reaction vessel, cylindrical, graduated, with tempering and vacuum jacket and drain valve, DN 150, 500 ml, 120 mm, 1 Piece

3-[5-(AMINOMETHYL)-1-OXO-2,3-DIHYDRO-1H-ISOINDOL-2-YL]PIPERIDINE-2,6-DIONE HYDROCHLORIDE, 95%, 250mg

1H-indazole, 98%, 10g

6-Chloro-N-(3-chloro-4-methylphenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine, 95.0%, 500mg

2-Phenylthiomorpholin-3-one, 95.0%, 500mg

(1H-Indazol-4-yl)methanamine dihydrochloride, 95.0%, 250mg

6-Chloro-7-deazapurine>98.0%(GC)(T)5g

2-(Tritylthio)acetic acid, 97.0%, 1g

1-(tert-Butyl) 2-methyl (2S,4R)-4-((tert-butyldiphenylsilyl)oxy)pyrrolidine-1,2-dicarboxylate, 95%, 1g